Pakistan set for new regulatory system:
This article was originally published in Clinica
Executive Summary
Pakistan is in the process of approving a new, autonomous agency that will regulate medical devices, to be named the Drug Regulatory Authority. Prime Minister Shaukat Aziz approved the establishment of the DRA at a meeting of senior health officials this month. Designed to streamline the registration of medical products, its responsibilities would include: the enforcement of regulatory laws; accessibility to safe and effective medicines and devices; and rationalisation of pricing. The draft Drug Regulatory Authority Act has been finalised in consultation with stakeholders. Registration documents required for establishing the new authority are yet to be presented to the cabinet for approval.
You may also be interested in...
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
P&G Restores Volume Growth In Beauty, Grooming After Pricing Run
Procter & Gamble reports strong consumer spending in the US and Europe after a 3% increase in product pricing over the past year. Dragging on fiscal third-quarter results, sales of SK-II in China fell 30% for the January-March period, while lower incidence of cough and cold impacted Health Care performance.
BMS Has A Strong Pipeline, But Access Challenges Remain
Bristol Myers Squibb’s head of major markets, Monica Shaw, wants to improve patients’ access to lifesaving therapies. And the group has several new products ready to roll.